The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics
Open accessAbstract
HIV entry inhibitors include coreceptor antagonists and the fusion inhibitor T-20. T-20 binds the first helical region (HR1) in the gp41 subunit of the viral envelope (Env) protein and prevents conformational changes required for membrane fusion. HR1 appears to become accessible to T-20 after Env binds CD4, whereas coreceptor binding is thought to induce the final conformational changes that lead to membrane fusion. Thus, T-20 binds to a structural intermediate of the fusion process. Primary viruses exhibit considerable variability in T-20 sensitivity, and determinants outside of HR1 can affect sensitivity by unknown mechanisms. We studied chimeric Env proteins containing different V3 loop sequences and found that gp120/coreceptor affinity correlated with T-20 and coreceptor antagonist sensitivity, with greater affinity resulting in increased resistance to both classes of entry inhibitors. Enhanced affinity resulted in more rapid fusion kinetics, reducing the time during which Env is sensitive to T-20. Reduced coreceptor expression levels also delayed fusion kinetics and enhanced virus sensitivity to T-20, whereas increased coreceptor levels had the opposite effect. A single amino acid change (K421D) in the bridging sheet region of the primary virus strain YU2 reduced affinity for CCR5 and increased T-20 sensitivity by about 30-fold. Thus, mutations in Env that affect receptor engagement and membrane fusion rates can alter entry inhibitor sensitivity. Because coreceptor expression levels are typically limiting in vivo , individuals who express lower coreceptor levels may respond more favorably to entry inhibitors such as T-20, whose effectiveness we show depends in part on fusion kinetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1240 · Cited by 1,358
Connor, R. I., Chen, B. K., Choe, S., & Landau, N. R. (1995) · Virology · doi:10.1006/viro.1995.1016 · Cited by 1,253
Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2855-2864.1998 · Cited by 1,219
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Self-citationA Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8358-8367.2000 · Cited by 742
Self-citationLee, B., Sharron, M., Montaner, L. J., Weissman, D., & Doms, R. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5215 · Cited by 579
Self-citationMelikyan, G. B., Markosyan, R. M., Hemmati, H., Delmedico, M. K., Lambert, D. M., & Cohen, F. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.413 · Cited by 576
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
Michael, N. L., Chang, G., Loum, L. G., Mascola, J. R., Dondero, D., Birx, D. L., & Sheppard, H. W. (1997) · Nature Medicine · doi:10.1038/nm0397-338 · Cited by 448
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Doms, R. W., & Moore, J. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.f9 · Cited by 296
Self-citationKuhmann, S. E., Platt, E. J., Kozak, S. L., & Kabat, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7005-7015.2000 · Cited by 223
Chen, B. K., Saksela, K., Andino, R., & Baltimore, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.654-660.1994 · Cited by 202
Kilby, J. M., Lalezari, J. P., Eron, J. J., Carlson, M., Cohen, C., Arduino, R. C., Goodgame, J. C., Gallant, J. E., Volberding, P., Murphy, R. L., et al. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202760072294 · Cited by 198
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Zhang, Z., O'Brien, W. A., Ratner, L., Shaw, G. M., & Hunter, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8605-8614.2001 · Cited by 182
Self-citationAlexander, W. A., Moss, B., & Fuerst, T. R. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2934-2942.1992 · Cited by 158
Weissenhorn, W., Wharton, S. A., Calder, L. J., Earl, P. L., Moss, B., Aliprandis, E., Skehel, J. J., & Wiley, D. C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00494.x · Cited by 137
Gallo, S. A., Puri, A., & Blumenthal, R. (2001) · Biochemistry · doi:10.1021/bi0155596 · Cited by 132
Self-citationHung, C., Heyden, N. V., & Ratner, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8216-8226.1999 · Cited by 121
Hoffman, T. L., Canziani, G., Li, J., Rucker, J. B., & Doms, R. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190274097 · Cited by 113
Self-citationIncreased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection
Stewart, G. J., Ashton, L. J., Biti, R. A., Ffrench, R. A., Bennetts, B., Newcombe, N. R., Benson, E. M., Carr, A. D., Cooper, D. A., & Kaldor, J. M. (1997) · AIDS · doi:10.1097/00002030-199715000-00007 · Cited by 110
Leapman, R. D., Lebowitz, J., Arthur, L. O., Earl, P. L., & Moss, B. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7863-7867.2002 · Cited by 102
Strong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100
Tremblay, C. C. L., Kollmann, C. S., Giguel, F. F., Chou, T., & Hirsch, M. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200010010-00001 · Cited by 98
Tremblay, C. L., Giguel, F. F., Kollmann, C. S., Guan, Y., Chou, T., Baroudy, B. M., & Hirsch, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1336-1339.2002 · Cited by 86
Reeves, J. D., & Schulz, T. F. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1453-1465.1997 · Cited by 78
Self-citation
Cited by
Harrison, S. C. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1456 · Cited by 1,190
González-Scarano, F., & Martín-García, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1527 · Cited by 1,097
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Metadata
- Authors
- Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., Hunter, E., & Doms, R. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-11-20
- Volume
- 99
- Issue
- 25
- Pages
- 16249-16254
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2048336729
- Cited by
- 404
- References
- 30
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.